Addictions, Social Deprivation and Cessation Failure in Head and Neck Squamous Cell Carcinoma Survivors.

alcohol abstinence cancer survivors head and neck neoplasms social deprivation tobacco use cessation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
15 Feb 2023
Historique:
received: 19 12 2022
revised: 24 01 2023
accepted: 07 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

To evaluate the evolution of addictions (tobacco and alcohol) and social precarity in head and neck squamous cell carcinoma survivors when these factors are addressed from the time of diagnosis. Addictions and social precarity in patients with a new diagnosis of HNSCC were assessed through the EPICES score, the Fagerström score, and the CAGE questionnaire. When identified as precarious/dependent, patients were referred to relevant addiction/social services. One hundred and eighty-two patients were included. At the time of diagnosis, an active tobacco consumption was associated with alcohol drinking (Fisher's exact test, At one year, addictions and social deprivation tend to improve when taken care of from the diagnosis. The most dependent patients and those with multiple frailties are at highest risk of cessation failure.

Identifiants

pubmed: 36831573
pii: cancers15041231
doi: 10.3390/cancers15041231
pmc: PMC9953762
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Addict Behav. 2016 Feb;53:175-80
pubmed: 26547043
Curr Oncol. 2022 Mar 02;29(3):1544-1558
pubmed: 35323330
JAMA. 1984 Oct 12;252(14):1905-7
pubmed: 6471323
Glob Adv Health Med. 2019 Apr 30;8:2164956119847117
pubmed: 31069164
J Health Care Poor Underserved. 2009 May;20(2):489-506
pubmed: 19395844
PLoS One. 2020 Nov 24;15(11):e0242693
pubmed: 33232348
Head Neck. 2018 Jul;40(7):1389-1399
pubmed: 29485685
Oral Oncol. 2001 Sep;37(6):513-20
pubmed: 11435178
Int Rev Neurobiol. 2015;124:209-43
pubmed: 26472531
Cancer. 2013 Jul 1;119(13):2419-26
pubmed: 23575663
Addict Behav. 2018 Jul;82:174-181
pubmed: 29547799
Eur J Public Health. 2015 Aug;25(4):604-9
pubmed: 25624273
Int J Cancer. 2013 Dec 1;133(11):2688-95
pubmed: 23719996
Int J Environ Res Public Health. 2017 Feb 25;14(3):
pubmed: 28245612
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2203-8
pubmed: 17119047
Cancer Med. 2015 Oct;4(10):1612-9
pubmed: 26250857
Int J Cancer. 2018 Sep 1;143(5):1114-1127
pubmed: 29607493
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Head Neck. 2020 Sep;42(9):2440-2452
pubmed: 32476217
Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-395
pubmed: 30078696
Cancer. 2006 Jan 1;106(1):17-27
pubmed: 16311986
J Oncol Pract. 2013 Sep;9(5):258-62
pubmed: 23943904
Head Neck. 2018 Aug;40(8):1845-1853
pubmed: 29603464
Ann N Y Acad Sci. 2012 Feb;1248:107-23
pubmed: 22092035
JAMA Otolaryngol Head Neck Surg. 2018 Jan 01;144(1):43-50
pubmed: 29121146
Int J Cancer. 2008 Jan 1;122(1):155-64
pubmed: 17893872
Oral Oncol. 2010 Mar;46(3):200-3
pubmed: 20138799
Neuropharmacology. 2017 Aug 1;122:3-21
pubmed: 28118990
Curr Oncol. 2020 Oct;27(5):e478-e485
pubmed: 33173387
Psychosomatics. 2007 Mar-Apr;48(2):142-8
pubmed: 17329608
Med Clin North Am. 2004 Nov;88(6):1453-65, x
pubmed: 15464107
Cancer Metastasis Rev. 2017 Sep;36(3):425-434
pubmed: 28815324
Int J Cancer. 2008 Jun 15;122(12):2811-9
pubmed: 18351646
J Am Acad Psychoanal. 1993 Spring;21(1):89-105
pubmed: 8509291
Addiction. 2008 Oct;103(10):1731-43
pubmed: 18705686
Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3337-45
pubmed: 26874733
Int J Public Health. 2009;54(4):203-12
pubmed: 19347249
Nicotine Tob Res. 2012 Dec;14(12):1467-73
pubmed: 22467778
Addict Behav. 2013 Jul;38(7):2306-12
pubmed: 23584190
Cancer. 2013 Aug 1;119(15):2701-9
pubmed: 23765604
Alcohol Clin Exp Res. 2000 Jan;24(1):53-7
pubmed: 10656193
Lancet Public Health. 2020 Jan;5(1):e42-e50
pubmed: 31837974
Acta Otorhinolaryngol Ital. 2017 Dec;37(6):458-466
pubmed: 28663597
J Occup Environ Med. 2007 Apr;49(4):437-45
pubmed: 17426527

Auteurs

Lara Nokovitch (L)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Yonjae Kim (Y)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Philippe Zrounba (P)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Pierre-Eric Roux (PE)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Marc Poupart (M)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Rabiha Giagnorio (R)

Medical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Dominique Triviaux (D)

Medical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Charles Maquet (C)

ENT Department, CHU de Rouen, 76000 Rouen, France.

Jennifer Thollin (J)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Nathalie Arantes (N)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Nathalie Thomas (N)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.

Béatrice Fervers (B)

Prevention Cancer Environment Department, Centre Léon Bérard, 28 Rue Laënnec, 69008 Lyon, France.
Inserm, U1296 Unit, "Radiation: Defense, Health and Environment", Centre Léon Bérard, 28 Rue Laënnec, 69008 Lyon, France.

Sophie Deneuve (S)

Surgical Oncology Department, Centre Léon Bérard, UNICANCER, 69008 Lyon, France.
Inserm, U1296 Unit, "Radiation: Defense, Health and Environment", Centre Léon Bérard, 28 Rue Laënnec, 69008 Lyon, France.

Classifications MeSH